Weight Loss

Novo Nordisk secures US FDA approval for first weight-loss pill

US-listed shares of Novo jumped 8 per cent and Lilly fell 1 per cent in extended trading after the approval announcement

Novo gets US nod for Wegovy pill, eyes January launch in obesity market

Novo will start selling the pill, the first of the blockbuster GLP-1 class, in the US in early January, the company said in a statement Monday

How fatherhood helped Ed Sheeran lose 14 kg and transform his health

Fatherhood, not fame, became the turning point in Ed Sheeran's health journey, prompting gradual lifestyle changes that improved both his physical and mental wellbeing

Mounjaro and the brain: Why cravings fade at first, then return later

A rare brain-recording study found tirzepatide briefly muted activity linked to 'food noise'; months later the signals and intrusive thoughts returned, hinting at limits to its effect

How isabgol improves gut function and supports weight management

Long used for digestion, psyllium husk or isabgol is now being linked to better gut health, appetite control and modest weight loss. Here's how it works and how to use it safely

Ozempic in India: What it does and how it fits into a growing health crisis

From regulating appetite to improving blood sugar control, GLP-1 drugs like Ozempic are emerging as powerful metabolic tools at a time when India urgently needs better solutions

Novo Nordisk launches Ozempic in India at ₹2,200/week amid patent battles

Ozempic debuts in India at ₹2,200 per week, offering a new treatment option for type 2 diabetes as demand grows for effective and easy-to-use metabolic health therapies

Delhi HC allows Sun Pharma to manufacture, export its weight loss drug

The approval marks a major win for Sun Pharma in its patent dispute with Danish drugmaker Novo Nordisk, the company that manufactures weight loss drug Ozempic

Healthify seeks more weight-loss drug partnerships after Novo Nordisk deal

The deal marks Healthify's first such partnership with a drugmaker, and it hopes similar agreements will boost its paid subscriber base

Can Ozempic trigger depression or suicidal thoughts? Australia weighs in

Australia has issued a safety alert on GLP-1 drugs after reviewing reports of depression and suicidal thoughts; while there is no proven causal link, regulators want users to stay alert

WHO calls for 'responsible use' of GLP-1 drugs for long term obesity care

The guideline reframes obesity as a chronic disease needing lifelong care, recommending GLP-1 therapies with behavioural support rather than relying on medication alone

Good old kalonji may help control fat and cholesterol, says new study

A new clinical trial shows that kalonji, long used in Indian kitchens, may help lower cholesterol and slow fat formation, offering a natural metabolic boost alongside regular diet and lifestyle habits

Rising demand for GLP-1 weight-loss drugs reshaping diagnostics market

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

Can weight-loss drugs like Ozempic help reduce alcohol and drug cravings?

Research suggests GLP-1 injections like Ozempic and Zepbound may dampen alcohol and drug cravings by lowering dopamine reward responses, but larger human trials are still underway

Why alcohol may hit harder for people on GLP-1 drugs like Ozempic, Wegovy

A Yale study suggests GLP-1 drugs like semaglutide slow alcohol breakdown in the liver, raising blood alcohol levels even as they reduce toxic byproducts linked to inflammation and liver damage

Novo sticks to oral semaglutide amid rising demand for injectables

Novo Nordisk will strengthen its oral semaglutide portfolio led by Rybelsus while cutting Wegovy injection prices by up to 37% to improve accessibility and expand its market in India

Ten diabetes-friendly grains to steady blood sugar and support weight loss

World Diabetes Day 2025: Experts say shifting from high-GI staples to low-GI grains can help steady blood sugar, curb cravings, improve satiety, and support weight control with simple grain rotation

Novo Nordisk cuts weight-loss drug Wegovy prices by up to 37% in India

Move comes in a bid to gain more space in India's anti-obesity market dominated by Mounjaro

Why losing weight is harder than we think, and how evolution has shaped it

Advances in obesity and metabolism research may mean that future therapies can be able to turn down these signals that drive the body back to its original weight, even beyond the treatment period

Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk's reach is limited